Related Experiment Video
Updated: Jun 3, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Assessing Type 2 Diabetes Risk in the Post-Pandemic Era: A Pharmacy-Led FINDRISC Screening Study
Victoria Bell1,2, Ana Rita Rodrigues1, Vera Costa1
1Social Pharmacy and Public Health Laboratory, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
Community pharmacies effectively screen for type 2 diabetes (T2D) risk using the Finnish Diabetes Risk Score (FINDRISC). Post-pandemic assessments reveal significant T2D risk factors, highlighting the crucial role of accessible screening.
Area of Science:
- Endocrinology
- Public Health
- Pharmacology
Background:
- Type 2 Diabetes (T2D) poses a significant global health challenge, with over 90% of diabetes mellitus (DM) cases attributed to T2D.
- Community pharmacies offer accessible points for early T2D detection and management.
- The COVID-19 pandemic's impact on T2D risk profiles requires evaluation.
Purpose of the Study:
- To evaluate post-pandemic T2D risk in a Portuguese population using the Finnish Diabetes Risk Score (FINDRISC).
- To assess the role of community pharmacies in identifying individuals at high risk for T2D.
- To identify key risk factors associated with T2D in the studied population.
Main Methods:
- Utilized the Finnish Diabetes Risk Score (FINDRISC) for risk assessment.
- Screened 494 participants aged 40+ without prior diabetes diagnosis across five community pharmacies.
- Collected data on risk factors including age, BMI, waist circumference, physical activity, family history, and educational level. Measured glycated hemoglobin (HbA1c) for referred participants.
Main Results:
- The mean FINDRISC score was 12.3.
- 29.8% of participants were identified as high or very high risk for T2D.
- 8.7% of participants with elevated HbA1c were referred for further medical evaluation. Key risk factors identified were age, BMI, waist circumference, physical inactivity, family history, and lower education levels. Pre-pandemic and post-pandemic FINDRISC results showed similar risk profiles.
Conclusions:
- Community pharmacies are vital for screening and educating populations at risk of T2D.
- FINDRISC is a cost-effective tool for community pharmacy-based T2D risk assessment.
- Lifestyle modifications (physical activity, diet) and regular monitoring are crucial for mitigating T2D risk. The COVID-19 pandemic did not significantly alter the overall T2D risk profile in this population.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

